Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹31,227Qualified Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj J 54 ASHIYANA COLONY KANPUR ROAD GAUTAMBUDH MARG LUCKNOW UTTAR PRADESH 226002 | LUCKNOW | UTTAR PRADESH | 226002 | Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj | L1 | Qualified MSE, Category: General | |
| 2 | L2₹40,350+₹9,123 (29.2%)Qualified Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj 00 RURA KANPUR DEHAT UTTAR PRADESH 209303 | KANPUR DEHAT | UTTAR PRADESH | 209303 | Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj | L2 | Qualified MSE, Category: General | |
| 3 | L3₹48,180+₹16,953 (54.3%)Qualified Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj | Item Categories: PyrantelPamoate USP Paste 11 point 41g in 26 g syringe,Calcium 9mg pluse Calcium gluconate 50mg Inj | L3 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
10 Jan 2025, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
PyrantelPamoate USP Paste 11 point 41g in 26 g syringe
Calcium 9mg pluse Calcium gluconate 50mg Inj for IV use 10 ml Injection
Inj Sodium Bicarbonate 7 point 5 percent solution amp of 10ml
Inj Dexamethasone Sodium phosphate 4 point 4mg vial of 10 ml
InjTonophosphan 20 percent vial of 30ml sod salt of 4 dimethyl amine2 methyl phenylphosphonic acid as 20 percent solution
Injpheniramine Maleate 22 point 57 mg per ml vial of 10ml
L Ornithine L Asparate 5gm 10ml Inj
7276336
GEM/2024/B/5731141
Single Packet Bid
PyrantelPamoate USP Paste 11 point 41g in 26 g syringe
15 days
Meerut, Uttar Pradesh
Total value wise evaluation
BOQ
3 documents required · 3 mandatory
3 yrs
10%
Exempted
10 Jan 2025
19 Dec 2024
10 Jan 2025
PyrantelPamoate USP Paste 11 point 41g in 26 g syringe
Calcium 9mg pluse Calcium gluconate 50mg Inj for IV use 10 ml Injection
Inj Sodium Bicarbonate 7 point 5 percent solution amp of 10ml
Inj Dexamethasone Sodium phosphate 4 point 4mg vial of 10 ml
InjTonophosphan 20 percent vial of 30ml sod salt of 4 dimethyl amine2 methyl phenylphosphonic acid as 20 percent solution
Injpheniramine Maleate 22 point 57 mg per ml vial of 10ml
L Ornithine L Asparate 5gm 10ml Inj
PyrantelPamoate USP Paste 11.41g in 26 g syringe
Calcium (9mg) + Calcium gluconate (50mg) Inj for IV use
10 ml Injection
Inj Sodium Bicarbonate 7.5% solution amp of 10ml
Inj Dexamethasone Sodium phosphate 4.4mg vial of 10 ml
InjTonophosphan 20% vial of 30ml (sod salt of 4- dimethyl amine-2 methyl phenylphosphonic acid as 20% solution)
Injpheniramine Maleate 22.57 mg per ml vial of 10ml
L-Ornithine L Asparate 5gm
10ml Inj Bid Number ( ) : GEM/2024/B/5731141 Dated : 19-12-2024 Bid Document 1/9
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7276336.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
post_sanction__-4_2024-12-19-21-39-25_f57a34905606f8489911ab00e6f15059.pdf
BOQ
boq_item_sample_file_-12_2024-12-19-21-39-25_32fd3a415c8b52c5de15bfb554a62618.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .